“Adjuvant Topical Dorzolamide or Timolol With Intravitreal Bevacizumab for Diabetic Macular Edema: A Double-Blind Randomized Controlled Trial”. 2024. Journal of Current Biomedical Reports 5 (1): 14-19. https://doi.org/10.61882/jcbior.5.1.279.